UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (date of earliest event reported):June 6, 2017
OXFORD IMMUNOTEC GLOBAL PLC
(Exact name of registrant as specified in its charter)
England and Wales
(State or other jurisdiction
of incorporation)
| | | |
001-36200 | | Not Applicable |
(Commission
File Number) | | (IRS Employer
Identification No.) |
94C Innovation Drive, Milton Park, Abingdon OX14 4RZ, United Kingdom
(Address of principal executive offices)
Registrant’s telephone number including area code +44 (0) 1235 442780
Check appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ | Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒
Item 5.07 Submission of Matters to a Vote of Security Holders
(a) On June 6, 2017, the Registrant held its Annual General Meeting of Shareholders (the “Meeting”).
(b) The final voting results for the Meeting are as follows:
Proposal Number | Proposal Description | For | Against | Abstain | Broker Nonvote |
1 | Election of Patrick J. Balthrop, Sr. | 16,000,615 | 61,879 | 4,218 | 1,365,572 |
2 | Election of Patricia Randall | 14,784,644 | 1,277,850 | 4,218 | 1,365,572 |
3 | Election of Herm Rosenman | 16,003,033 | 58,611 | 5,068 | 1,365,572 |
4 | Ratification of Appointment of Auditors for 2017 | 17,425,616 | 653 | 6,015 | 0 |
5 | Re-Appointment of U.K. Statutory Auditors | 17,424,003 | 449 | 7,832 | 0 |
6 | Authorization to Determine Statutory Auditors’ Remuneration for 2017 | 17,425,890 | 379 | 6,015 | 0 |
7 | Receive U.K. Statutory Accounts and Reports for 2016 | 17,393,001 | 304 | 38,979 | 0 |
8 | Receive and Approve U.K. Statutory Directors’ Annual Report on Remuneration for 2016 | 17,342,455 | 83,702 | 6,127 | 0 |
9 | Approve Directors’ Remuneration Policy | 17,341,451 | 81,396 | 9,437 | 0 |
10 | Approve Amendment of 2013 Share Incentive Plan | 14,135,089 | 1,926,595 | 5,028 | 1,365,572 |
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: 6/7/2017
| | | |
OXFORD IMMUNOTEC GLOBAL PLC |
| | |
| |
By: | | /s/ Elizabeth M. Keiley |
| | | |
Name: | | Elizabeth M. Keiley |
| | | |
Title: | | SVP & General Counsel |
